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Induction of Mammary Neoplasms in the Sprague-Dawley Rat by 
430-keV Neutrons and X-Rays 3 
Claire J. Shellabarger, 4 Danielle Chmelevsky, 5 and Albrecht M. Kellerer 5 * 6 ' 7 
ABSTRACT—Female noninbred Sprague-Dawley rats were ex-
posed to Single doses of 0.28, 0.56, and 0.85 gray (Gy=?1 J/kg or 
100 rads) of X-rays or 0.001, 0.004, 0.016, and 0.064 Gy of 430-
keV neutrons at 62±1 days of age and were then observed over 
the rest of their llves for the appearance of mammary neoplasla. 
As mammary neoplasms were detected, they were removed and 
glven a Classification of adenocarclnoma(s) (AC) or flbroade-
noma(s) (FA) after mlcroscoplc study. All Irradlated groups 
exhlblted an Increased Incldence of mammary neoplasla. The 
tumor rate increased steeply with age of the anlmals, and the 
effect of the Irradiation could be adequately described as a 
forward shift In tlme of the spontaneous Incldence. The cumula-
tlve prevalence was derlved from first neoplasms only, and a 
formalism was presented that makes It possible to derlve the 
integral tumor rate from all neoplasms In all anlmals. Mortallty-
corrected cumulative prevalences and Integral tumor rates as a 
function of age were glven for the different doses and separately 
for FA and AC. The mammary FA response and the total 
mammary neoplastlc response (Includlng both FA and AC) were 
approxlmately proportional to the absorbed dose of X-rays or the 
square root of the neutron dose. The relative blological effective-
ness (RBE) of the neutrons Increased with decreaslng dose and 
reached values exceeding 100 at a neutron dose of 1 mGy; 4he 
Single dose of 1 mGy of neutrons produced a slgnlficant Increase 
of the tumor rate that corresponded to a foward shlft or roughly 
35 days of the spontaneous Incldence. The AC, taken separately, 
were subject to conslderable Statistical uncertaintles due to their 
small numbers. However, their RBE-dose dependence was con-
slstent with that for the FA and, even at the highest dose studied, 
the RBE value exceeded 10. The nonrandom development of 
multiple FA wlthin indlvldual anlmals appeared to be the result of 
dlfferences In susceptiblllty to radlation. However, mammary FA 
and AC withln Indlvldual anlmals were not statistlcally corre-
lated.—JNCI 64: 821-833, 1980. 
This article presents the results of an extensive 
experimental investigation on the induction of mam-
mary tumors in the Sprague-Dawley rat by 430-keV 
neutrons and by X-rays. Earlier studies with various 
biologic Systems revealed a maximum of the effective-
ness of neutrons at an energy around 400 keV; they 
also showed that RBE increases with decreasing neu-
tron dose and that it can exceed values of 100. These 
results, which are in agreement with microdosimetric 
considerations ( 1 - 3 ) , have suggested the present experi-
ment designed with special emphasis on the effects of 
low neutron doses. The Sprague-Dawley rat is well 
suited for studies in the low-dose ränge because it is 
particularly prone to develop early mammary neo-
plasms (4) in response to radiation and to certain 
chemical carcinogens. 
Earlier studies dealt with the effects of low L E T 
radiation (5-8) and of high-energy neutrons (9-11) and 
even more recently with the effects of high L E T 
particles (12). From data for fission neutrons (9y 11) 
and X-rays (10), Vogel and Zaldivar inferred RBE 
values in the ränge of 20-60. The present experiment 
comprises concurrent neutron and X-irradiations and is 
aimed at the determination of dose-effect relations as 
well as the dependence of RBE on neutron dose. 
An interim report on the result of the experiment up 
to 400 days after irradiation has been given earlier (13). 
The conclusions, drawn in this earlier report on the 
RBE of neutrons versus X-rays and gamma rays, have 
now been confirmed by the results of the completed 
experiment. However, current results permit, in ad-
dition, a more detailed analysis of the tumor rate as 
a function of time and absorbed dose of X-rays or 
neutrons. Due to the sharp increase in spontaneous 
tumor rate with increasing age of the animals, the 
analysis poses a number of conceptual and formal 
Problems that will be dealt with in detail. 
MATERIALS AND METHODS 
Weanling female Sprague-Dawley rats were pur-
chased from Sprague-Dawley Inc., Madison, Wiscon-
sin, and maintained on commercial rat chow and water 
ad libitum in temperature-controlled (22±2° C) and 
humidity-controlled (55±10%) animal rooms under con-
ditions of 12 hours of fluorescent light per day. A 
single lot of 742 rats, all born on the same day, was 
numbered consecutively by the withdrawal of 1 rat 
ABBREVIATIONS USED: A C = adenocarcinoma(s); FA=fibroadenoma(s); 
Gy = gray, unit of absorbed dose in the International System of Units 
( = 1 J/kg or 100 rads); LET=linear energy transfer; RBE = relative 
biological effectiveness. 
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3 Animals were maintained under the guidelines set forth by the 
American Association for Accreditation of Laboratory Animal Care. 
4 Medical Department, Brookhaven National Laboratory, Upton, 
N.Y. 11973. 
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Federal Republic of Germany. 
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from each of the 30 shipping cartons. From the 
consecutively numbered animals, the required numbers 
of rats were then assigned to each experimental group 
and to the control group. When they were 61-63 days 
old, the animals were exposed either to neutrons, X-
rays, or sham radiation. Five rats were then assigned to 
a single cage on a random basis independently of 
treatment. Each rat was examined frequently, and 
when breast tumors were noted by palpation, the 
tumors were removed surgically from the rats under 
ether anesthesia, and the rat was then returned to the 
experiment. No animal was killed, unless death ap-
peared imminent, until 1,033-1,053 days of study when 
19 rats, from a starting number of 742, were killed to 
terminate the experiment. Individual records were kept 
for each rat, and the time of appearance and anatomic 
location of the breast tumors were recorded. Mammary 
neoplasms that occurred in different quadrants in the 
same animal were considered to be separate neoplasms. 
If successive mammary neoplasms were noted in the 
same quadrant, they were considered to be different 
neoplasms only if they were of a different pathologic 
type. If they were of the same pathologic type, they 
were considered different neoplasms provided that at 
least 6 months had elapsed between removal of the first 
neoplasm and detection of the second neoplasm. All 
mammary neoplasms, after microscopic study, were 
given a pathologic Classification of either AC or FA 
according to criteria published previously (7). All data 
concerned with death or time of appearance of mam-
mary neoplasia are reported in days after the 62d day of 
age. 
Neutron irradiations were accomplished as follows: 
Twenty-three rats were rotated in a vertical carousel or 
Ferris wheel 30 cm from a water-cooled tri dum target. 
Each rat was placed in a cylinder 5 cm in diameter and 
17.5 cm long made of Lucite 0.3 cm thick and 
weighted so that the animal remained in its normal 
horizontal Standing position while the wheel was 
rotating. 
A Van de Graaff generator was operated to bombard 
the target with 2.43-MeV protons to produce neutrons 
with an energy of 430 keV at the midpoint of each 
cylinder. The geometry was such that within the rat 
maximal deviations of the neutron energy from +28 to 
— 14% of the midpoint energy occurred. All rats were 
reversed in their cylinders after one-half of the dose had 
been given to reduce nonuniformity in the energy and 
absorbed dose distributions. The mean tissue kerma in 
free air was measured at the locations of the rats by 
integration of the response of a rat-sized, homogeneous 
tissue-equivalent ionization Chamber of minimal mass 
placed in the 24th cylinder. A compensated Geiger-
Müller dosimeter indicated a gamma ray component to 
the kerma of 3.5%. Depth-dose measurements were 
made to determine the ratio of absorbed dose to 
neutron kerma. For this purpose, a 0.6-cm spherical 
tissue-equivalent multiplication Chamber was inserted 
into a nylon rat phantom at four radial depths. The 
ratio of absorbed dose to neutron kerma varied between 
0.75 and 0.88 over the entire presumed volume of the 
rat mammary tissue. In the following, a factor of 0.8 
was used to convert neutron kerma to neutron-absorbed 
dose. The neutron kerma rate was approximately 40 
mGy/hour. The rats were exposed to a total kerma of 
1.25, 5.0, 20, or 80 mGy, which is considered to be the 
equivalent of 1.0, 4.0, 16, or 64 mGy of absorbed dose, 
respectively. 
X-ray exposures were accomplished with a conven-
tional therapy X-ray machine. The exposure conditions 
were: 100 cm target-to-specimen distance; 0.5 mm Cu 
plus 1.0 mm aluminum filter; maximum backscatter, 
250 kVp; and an exposure rate of 30 R/minute measured 
with a 100-R Victoreen Chamber at the dorsal-ventral 
midpoint of the rats. Rats received an exposure of 30, 
60, or 90 R. With a conversion factor of 0.0094, this 
exposure correspondfcd to 0.28, 0.56, or 0.85 Gy of 
absorbed dose, respectively. 
RESULTS AND DISCUSSION 
S u m m a r y of observations.—In this section a Synopsis 
of the observations will be given in elementary form. 
The inadequacies of this conventional description will 
make it apparent, however, that a more rigorous analy-
sis is required. This kind of analysis will be the subject 
of the subsequent sections. 
M e a n n u m b e r a n d m e a n time of n e o p l a s m appear-
ance.—Radiation doses and numbers of animals in the 
irradiated groups are listed in table 1. Because the 
experiment was directed toward the elucidation of the 
effects of extremely low doses, the largest numbers of 
animals were assigned to the control group and to the 
group that was exposed to 1 mGy of neutrons. Table 1 
also gives the numbers of animals with specified 
numbers of FA and AC. It lists the mean numbers of 
tumors per animal throughout their lives and the 
Standard errors of these numbers. The mean values and 
their Standard errors are obtained by the formula 
i VVMX I ^ max 
* = T 7 I /Z (P-V)2ß/N(N-1), [1] 
N p = l V */=0 
where N is the total number of animals in the group 
and /xv is the number of animals that develop v 
neoplasms throughout their lifetimes. All the distribu-
tions of the number of tumors per animal in table 1 
are overdispersed; i.e., the variances of the distributions 
are broader than those of Poisson distributions. How-
ever, this in itself cannot be taken as proof that there 
are inherent variations in the tumor rates within each 
group of experimental animals. In fact, substantial 
deviations from the Poisson distributions arise from 
the variable life-spans of the animals together with the 
sharp increase in tumor rate with age. The detailed 
analysis in the subsequent sections of this article will 
nevertheless provide evidence for inherent variations in 
tumor rate among animals. 
Table 2 gives the fraction of animals with at least 1 
neoplasm each. In addition, the mean times of appear-
ance of the first neoplasms and of all neoplasms are 
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T A B L E 1 . — N u m b e r of r a t s with specified numbers of m a m m a r y neoplasms throughout their life-spans 
Dose 
type 
Initial 
No.of 
animals 
No. of animals with specified No. of FA 
throughout lifetime 
Mean 
No. of 
FA/ 
animal 
through-
out life-
t ime 0 
No. of animals with 
specified No. of AC 
throughout lifetime 
Mean 
No. of 
AC/ 
animal 
through-
out life-
t ime 0 
0 1 2 3 4 5 6 7 8 9 >10 0 1 2 3 4 
Controls 167 57 42 30 15 8 4 4 2 2 3 0 1.68±0.15 141 22 3 1 0 0.1910.04 
Neutron dose, Gy 
0.001 182 61 42 28 23 7 10 6 2 2 1 0 1.7610.14 154 24 3 1 0 0.1810.03 
0.004 89 27 24 12 6 7 6 2 3 1 0 1 1.98±0.23 67 19 2 1 0 0.2910.06 
0.016 68 16 14 11 9 3 5 2 1 1 3 3 2.74±0.34 53 11 3 1 0 0.2910.08 
0.064 45 11 6 8 7 4 1 1 1 0 2 4 3.18±0.46 28 10 6 1 0 0.5610.12 
X-ray dose, Gy 
0.28 95 31 30 9 7 9 1 4 1 2 1 0 1.75±0.21 73 17 5 0 0 0.2810.06 
0.56 48 13 7 8 6 6 2 3 1 0 0 2 2.5610.36 35 10 3 0 0 0.3310.09 
0.85 48 10 10 7 4 7 3 2 0 2 1 2 2.8810.39 31 11 2 4 0 0.5610.12 
Values are means i S E . 
TA B L E 2 . — M e a n life-span, fraction of r a t s with neoplasms, m e a n time of a p p e a r a n c e of first FA and A C , total number of neoplasms, a n d 
m e a n time of a p p e a r a n c e for all F A a n d A C 
Mean time Mean time Mean time Mean time Mean time Mean time 
Dose 
type 
Fraction of of appear- of appear- of appear- Total of appear- of appear- of appear-
animals with ance of ance of ance of first No.of ance of ance of ance of all 
neoplasms first FA, first AC, neoplasms, neoplasms all FA, all AC, neoplasms, 
days* days" days a days" days" days* 
Controls 112/167 = 0.67 587115 771125 590115 311 687110 788183 69719 
Neutron dose, Gy 
0.001 127/182 = 0.70 543116 712139 536115 353 663110 732134 670110 
0.004 67/89 =0.75 544118 613149 527120 202 655112 637143 653112 
0.016 54/68 =0.79 481125 668171 460125 206 666115 745162 674115 
0.064 38/45 =0.84 411126 415153 368126 164 572115 463143 556114 
X-ray dose, Gy 
0.28 68/95 =0.72 551123 655146 533123 193 644114 677141 648113 
0.56 37/48 =0.77 421128 521186 380130 138 580116 531172 575116 
0.85 38/48 =0.79 418131 637152 397130 165 589117 698137 607115 
a Values are means I S E . 
listed; the information is also given separately for the 
two types of neoplasms. 
In table 3 the mean tumor-free life-span is compared 
to the mean total life-span of the animals; this is done 
separately for all neoplasms and for the two types of 
neoplasia. A reduction of the mean tumor-free life-span 
reflects both radiation-induced mortality and tumor 
incidence. Even the comparison of the mean tumor-free 
life-span with the mean total life-span may not afford 
a reliable measure of radiation-induced tumors; this is 
evident if one considers substantial doses whereby 
animals may die too fast to develop tumors. However, 
in the present experiment radiation-induced mortality 
plays a minor role, at least at the lowest doses. 
Text-figure 1 represents, as a function of absorbed 
dose, the mean numbers of all neoplasms per animal 
throughout its life. Because the neutrons are far more 
effective than X-rays, dose scales differing by a factor of 
T A B L E 3 . — M e a n life-spans and m e a n life-spans free of m a m m a r y 
neoplasms for different n e u t r o n a n d X - r a y dosesa 
Mean Mean Mean 
Mean tumor- FA- AC-
Dose life- free free free 
type span, life- life- life-
days span, span, span, 
days days days 
Controls 748113 597113 599113 734113 
Neutron dose, Gy 
0.001 717114 543113 544113 696114 
0.004 724117 541117 564116 673119 
0.016 774120 500124 518123 734123 
0.064 643129 389128 424126 552135 
X-ray dose, Gy 
0.28 708118 539118 557118 675120 
0.56 729121 443131 476127 667132 
0.85 667126 415126 432127 628127 
a Values are means I S E . 
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N E U T R O N S 
D x / G R A Y 
T E X T - F I G U R E 1.—Mean No. of mammary neoplasms of any type, FA 
and AC, throughout life per animal as a function of neutron dose 
(Dn) and X-ray dose (Dx). Scales for the neutron dose and the X-ray 
dose differ by a factor of 10. 
10 are used for the two radiations. In text-figure 2 the 
difference between the mean tumor-free life-span in the 
irradiated groups and the control group is plotted as a 
function of absorbed dose. Again, the dose scales differ 
by a factor of 10. 
Both text-figures 1 and 2 indicate RBE values of 
neutrons versus X-rays of 100 or more at small doses. 
In addition, the two plots show a "sublinear" dose-
effect relation (dose exponent <1) for neutrons. The 
extraordinary character of such a dose dependence at 
low neutron doses makes it desirable to subject the data 
to a more rigorous analysis. Such an analysis must take 
into account the time dependence of the tumor appear-
ance. 
Time d e p e n d e n c e of observations.—Text-figure 3 
gives a rough representation of the observed time 
dependences. The data for each group are given in a 
separate panel. Four different categories of animals are 
shown, and the relative numbers at any time after 
irradiation are represented by differently marked areas. 
The solid line between the two shaded areas in text-
figure 3 indicates cumulative mortality. In these plots 
the mean life-spans listed in tables 2 and 3 are equal to 
the areas above the lines representing cumulative 
mortality. The mean tumor-free life-spans listed in 
D_ /GRAY 
.05 
0 .5 1 
D x / GRAY 
T E X T - F I G U R E 2.—Loss of tumor-free life in days for any type of 
mammary neoplasm, FA, and/or A C as a function of neutron dose 
(Dn) and X-ray dose (Dx). Scales for the neutron dose and the X-ray 
dose differ by a factor of 10. 
T I M E / D a y i 
T E X T - F I G U R E 3.—Fraction of animals dead or alive with and without 
a mammary neoplasm of any type, either FA and/or A C , as a func-
tion of time after irradiation. Fraction of animals dead without 
tumor; H» fraction of animals dead with at least 1 tumor; frac-
tion of animals alive with at least 1 tumor; fraction of animals 
alive without tumor. 
table 3 are equal to the upper unshaded areas. Strictly 
speaking, the curves in text-figure 3 should consist of 
discrete steps. However, here and in subsequent text-
figures the midpoints of the vertical steps are simply 
connected by sloping line Segments. This makes the 
text-figures easier to read. 
The increase in the piain shaded areas with increas-
ing dose reflects the increased tumor incidence. How-
ever, these areas are not a proper quantitative measure 
for the incidence of neoplasms. The enhanced mortal-
ity at higher doses, i.e., the decreased mean life-spans 
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of the animals, reduces the number of observed tumors. 
In text-figure 3 this leads to a decrease in the piain 
shaded areas and a Corresponding increase in the cross-
hatched area. 
Text-figure 3 does not convey all the information 
obtained from the experiment. A rigorous analysis will 
have to be based on the time dependence of the tumor 
rate, i.e., a quantity that requires somewhat more 
complicated calculations. 
DETAILED ANALYSIS 
Definition of Tumor Rate r(f) and 
Integral Tumor Rate R ( f ) 
For numerical analysis, it is necessary to give first a 
rigorous definition of essential quantities. Particularly 
important among these quantities is the tumor rate. 
The tumor rate r(t) is the probability per unit time 
interval for an animal to develop a neoplasm at time t. 
Because the actual time of origin of a neoplasm is 
unknown, it is identified with the time of first Observa-
tion. The analysis is not restricted to first neoplasms in 
an animal but includes all separate neoplasms. 
In a group of animals subjected to the same dose, the 
tumor rate may vary from animal to animal; i.e., some 
animals may have a greater inherent probability than 
others to develop neoplasms. This problem will be 
considered in a subsequent section; at present it is 
sufficient to note that the quantity r(t) must be 
interpreted as the average tumor rate in a group of 
animals at time t. In principle, the tumor rate at a 
specified time i in a group of N animals at risk can be 
estimated from an Observation of the number n of 
tumors appearing during a time interval At. This 
estimate of the tumor rate is 
r(t) = n 
N-At [2] 
In reality, such estimates may be difficult to obtain. 
For a moderate number of animals at risk and for a 
reasonably short time interval A* of not more than a 
few months, the number n of tumors appearing during 
the time interval may be small or even zero. This is 
particularly true in the initial phase of the experiment 
when the tumor incidence is much lower than at older 
ages. For the purpose of the numerical analysis, it will 
therefore be more practical to deal with a quantity that 
will here be called the integral tumor rate R(t): 
R(t) [3] 
This quantity is less affected by Statistical fluctua-
tions than is r(t) and is therefore more readily derived 
from experimental observations. R(t) is the expected 
number of neoplasms per animal at risk up to time t. 
The slope of R(t) versus t is equal to the tumor rate 
r(t). 
Estimation of Integral Tumor Rate and Its Standard 
Error 
There are different ways to estimate R(t) from the 
observed data. The most straightforward method is to 
equate R(t) with the mean number of neoplasms that 
have occurred up to time t in the surviving animals; 
this method is the so-called reduced sample estimate 
(14). It has, however, the disadvantage that all observa-
tions are disregarded that are made on animals not 
surviving up to time t. This results in large Statistical 
uncertainties at later times when few of the animals in 
each group survive. Moreover, the estimate could be 
biased by a correlation between mortality and incidence 
of neoplasms. 
Equations 2 and 3 permit an estimate of R(t) that is 
based on all tumors observed up to time t and that is 
closely related to the so-called actuarial estimate (14-16). 
An estimate R(t) of the integral tumor rate can be 
obtained from the relation 
Ä ( 0 = I — A « = I ^ for all i with i A t < t , [4] 
i N i k t i Ni 
where n, is the number of neoplasms appearing in the 
time interval (i— 1)A* to i-At, whereas Ni is the number 
of survivors at this time. Choosing sufficiently short 
time intervals A*, one reaches the point at which no 
neoplasm will appear in most of the intervals and the 
rest of the intervals will contain only 1 neoplasm. 
Equation 4 then reduces to 
*(0 = Z ^ - , [5] 
k N(tk) 
where tk are the times of appearance of the individual 
neoplasms up to time t, and N(tk) are the numbers of 
animals at risk at these times. This formula is utilized 
for the numerical evaluations. For simplicity of nota-
tion, the estimated values of the integral tumor rate 
will be designated by R(t) rather than by R(t). The less 
rigorous but also less technical term, mean number of 
tumors per animal, is used interchangeably with inte-
gral tumor rate. 
The numerical values resulting from equation 5 are 
represented by the upper solid curves in text-figure 4 
for FA and in text-figure 5 for AC. The curve for the 
controls is given together with each of the curves to 
facilitate comparison. 
The shaded areas give the Standard errors of R(t) 
calculated according to the formula (see "Appendix") 
oR{{) = ± / ^ * 2 , summation over all k with [6] 
V k N(tk) 
Dose-effect relations and the RBE-dose relation will be 
considered in detail in a later section. However, the 
very high effectiveness of low doses of neutrons is 
apparent even without further analysis. It is particu-
larly striking that a single dose of 1 mGy of neutrons 
leads to a visible increase in the incidence of FA. 
Application of the test that has earlier been described 
(17) and that is in essence a generalization of the so-
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called log-rank test (75, 16) leads to the conclusion that 
the increase is significant with an error level of less 
than 5%. 
A comparison with the curve for 0.28 Gy of X-rays 
leads us to the conclusion that the RBE for a neutron 
dose of 4 mGy exceeds 70 for FA. For AC one also 
obtains an RBE of 70 from the observed approximate 
equality of the effect of 4 mGy of neutrons and 0.28 Gy 
of X-rays. The small incidence of AC in the group 
exposed to 16 mGy of neutrons is not in line with the 
other observations, but this may be a fluctuation due to 
the small absolute numbers of AC. At the highest 
neutron dose studied, the Statistical accuracy is better 
and, as discussed in the subsequent section, it can be 
shown that the rate of AC is significantly higher for 
0.064 Gy of neutrons than for 0.85 Gy of X-rays. This 
implies that even at the highest dose the neutron RBE 
for A C exceeds 10. 
Comparison to Integral Tumor Rate Obtained From 
First Neoplasms per Animal and Connection 
Between R ( t ) and Cumulative Prevalence l ( t ) 
Estimates of the integral tumor rates could also be 
obtained by restriction of the analysis to the first 
neoplasm in each animal. The same equation 5 applies 
in this case. The only differences are that the summa-
tion extends only over first neoplasms and that the 
number N(tk) of animals at risk at time tk is not that of 
the survivors but that of the animals without neo-
plasms. In other words, the same formalism is applied, 
but the animals are removed from the analysis as soon 
as the first neoplasm is found. Regardless of whether 
all animals or only animals without previous neo-
plasms are retained in the analysis and provided all 
animals have the same inherent tumor rate that is 
unaffected by the occurrence of previous neoplasms, 
one should, on the average, obtain the same estimate 
R(t). Under this condition, the two estimates are 
equivalent; however, the estimates from all neoplasms 
are subject to less Statistical error because they are 
based on more data. 
A comparison of the values R(t) obtained from first 
tumors indicates, however, that animals with a previ-
ous neoplasm have a somewhat higher probability of 
developing further neoplasms. This phenomenon can 
be seen in text-figure 6 in which comparison of the 
two estimates is given for FA. In the early phase of the 
experiment, the two estimates coincide; at later times, 
the value R(t) obtained from all neoplasms is substan-
tially larger than the value obtained from first neo-
plasms only. The slopes of the solid lines in text-figure 
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6 are estimates of the tumor rate among all surviving 
animals, whereas the slopes of the broken lines are 
estimates of the tumor rate among animals with no 
previous neoplasms. One concludes, therefore, that 
there is indeed a somewhat higher tumor rate among 
animals with previous neoplasms. Inhomogeneity of 
the population is also evident from a consistent over-
dispersion of the distribution of the number of FA 
among animals surviving at a specified time. 
In other rat strains and mainly for carcinomas, 
Clifton and Crowley (18) have also demonstrated that 
animals with previous mammary neoplasms have a 
higher probability of developing further neoplasms. 
They concluded from these observations that the occur-
rence of a neoplasm increased the probability for 
further neoplasms, and they consequently restricted the 
analysis to first neoplasms. 
T I M E / D A Y S 
T E X T - F I G U R E 6.—Comparison of integral tumor rates R(t) for FA 
from computations based on all FA (solid lines) and on first FA 
only ( b r o k e n l i n e s ) . T o avoid overlap, different shifts of the Ordi-
nate values are applied to the curves. The numerical values on the 
ordinale apply, therefore, only to the unshifted pairs of curves. For 
the other curves, the ordinale values must be adjusted. 
There is no direct evidence that the presence of an 
FA in a Sprague-Dawley rat predisposes the animal to 
the development of additional neoplasms. In fact, it 
has been found (19) that there is no abscopal effect, i.e., 
no increased tumor rate in the unirradiated tissue if the 
mammary tissue is partially irradiated. In fact, overdis-
persion does not require that the incidence of a 
neoplasm increases the probability for further neo-
plasms in an animal. Instead, there may be inherent 
differences in the tumor rate between animals. Restric-
tion of the analysis to first tumors only would bias the 
results toward animals with the smallest tumor rate, 
and all neoplasms are therefore considered in the 
present analysis. 
There is no similar evidence for differences in the 
rate of A C (text-fig. 7), but the number of AC is so 
small that only a very substantial correlation would be 
observable. It would be easier to detect a correlation of 
the occurrence of AC with the number of FA in the 
same rat. However, no such correlation has been 
found. 
The probability of an animal to incur no neoplasm 
up to time t is equal to 
Po(0 
- f r ( t ' ) dt' 
= e J0 = e - R i t ) . [7] 
where r(t) and R(t) are the tumor rate and the 
cumulative tumor rate, respectively, for animals with 
no previous neoplasms. 
R ( t ) obtained from first neoplasms only can therefore 
be used for the calculation of the probability /(/) of an 
animal to incur at least 1 neoplasm up to time t: 
I ( t ) = l - e ' R { t ) . [8] 
l(t) is usually called cumulative prevalence (20) and is 
obtained by the product limit estimate of Kaplan and 
Meier (14). The computation from R(t) for first neo-
plasms, i.e., the computation based on equation 5, is 
used in the present analysis because it is somewhat 
simpler. The results are given in text-figure 8 for the 
two types of neoplasms separately. 
DOSE-EFFECT RELATIONS AND RBE-DOSE 
RELATION 
Dose-effect relations can be obtained readily on the 
basis of the excess number of neoplasms per animal at 
a specified time. The disadvantage of this procedure is 
that the choice of the time of reference is arbitrary, and 
one does not utilize all of the experimental data. 
Depending on the time of reference, one will obtain 
somewhat different curves. This is evident in text-
figure 9 in which the mean number of FA R(t) minus 
the control value is plotted for 400, 600, and 800 days 
as a function of neutron and X-ray doses. To accom-
modate all curves on a common graph, we chose the 
logarithmic representation. This representation has the 
additional advantage that linear dose-effect relations 
are easily recognized because they should appear as 
lines of unit slope. In spite of considerable Statistical 
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T E X T - F I G U R E 7.—Comparison of integral tumor rates R(t) for A C 
from computations based on all A C (solid lines) and on first A C 
only ( b r o k e n l i n e s ) . Vertical shifts of the curves are as in text-fig. 6. 
fluctuations, the same Observation that has been made 
from text-figures 1 and 2 is also apparent from text-
figure 9; this is the sublinearity, i.e., the dose exponent 
less than 1, for neutrons. For X-rays, a linear dose 
dependence cannot be excluded. The observations are 
therefore in agreement with earlier analyses (2, 3), and 
a dose exponent less than 1 at very low neutron doses 
appears to be well confirmed. This need not be 
inconsistent with the fact that no deviation from 
linearity was established in a similar experiment (21) 
involving smaller groups of animals, h i g h e r doses, and 
shorter times of Observation. 
It is unsatisfactory to represent the results of the füll 
experiment by dose-effect relations that contain only a 
minor fraction of the total information. A more com-
plete description is therefore desirable. One method to 
obtain this description is the representation of the 
observed integral tumor rates by certain analytic ex-
pressions and the examination of their dependence on 
absorbed dose. 
A comparison of the curves for FA (text-fig. 4) 
indicates that their shape is similar. One may therefore 
surmise that the effect of the irradiation consists in a 
shift in the occurrence of neoplasms to earlier times. 
This would be in line with other analyses of late effects 
which have led to the notion that the effect of 
irradiation can be equivalent to an age increment (22). 
One can on the basis of text-figure 4 estimate the time 
shifts produced by the different neutron and X-ray 
doses in regard to mammary FA. For this purpose, the 
individual curves in text-figure 4 are approximated by 
the relation 
R(t) = 7.5- 10 _ l°((*-A*)/[d]) 3' 3, [9] 
where [d] = day and R ( t ) = 0 for t < A t . This corresponds 
to the tumor rate 
r(t) = 2 . 5 ' \ 0 ~ 9 ( ( t - M ) / [ d ] ) 2 ' i i d Y l [10] 
and r(t) = 0 for t < A t . 
For the control group, A^=106 days. For the irradi-
ated groups the values A t are smaller, and the differ-
ence to the control value is the radiation-induced time 
shift in the occurrence of the mammary neoplasms. 
The time shifts that yield a good fit to the data are 
plotted for FA in text-figure 10 in which the scales for 
the neutron and the X-ray dose differ again by a factor 
of 10. As with text-figure 9, results are given here only 
for FA. However, nearly the same time shifts result if 
the analysis is based on all neoplasms. 
In contrast to the dose-effect relations in text-figures 
1, 2, and 9, text-figure 10 has the double ad van tage of 
being based on mortality-adjusted data and of being 
representative for all observations. A disadvantage is 
that there is no simple method to derive Standard 
deviations or confidence limits for the results. This will 
require further study. However, it is apparent that 
these dose-effect relations are also in agreement with 
the conclusion that the dose dependence of the induc-
üon of mammary neoplasms in Sprague-Dawley rats is 
sublinear at low doses of neutrons (dose exponent <1), 
whereas it is approximately linear for X-rays. 
One cannot assume that the different dose-effect 
relations that have been discussed here lead to precisely 
the same RBE of neutrons as a function of absorbed 
dose. The RBE values obtained from the various dose-
effect relations could be different if the effect of 
neutrons were qualitatively different from that of X-
rays, e.g., in the temporal distribution of tumors. 
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TEXT-FIGURE 9.—Excess No. of FA per animal at specified times 
after exposure to 430-keV neutrons or X-rays. Data correspond to 
those in text-fig. 4. B a r s are SE's. S o l i d l i n e s have no mathematical 
significance; they are inserted merely to clarify the representation. 
However, no indication is found in the present experi-
ment that such a qualitative difference exists. In fact, 
the dose-effect relations in text-figures 1, 2, 9, and 10 
are all consistent with the RBE-dose relation that is 
plotted in text-figure 11. 
The computation of confidence ranges for the RBE 
as a function of neutron dose would require the 
assumption of an analytic expression for the underly-
ing dose-effect relations. This will not be considered in 
the present article. Certain boundaries for the RBE 
values can, however, be obtained from direct compari-
son of the effects of a neutron dose and an X-ray dose 
(23). Application of a test (17) closely related to the 
log-rank test (15, 16) to the füll set of observations at, 
for example, a dose of 16 mGy of neutrons and 280 
mGy of X-rays shows that the latter is significantly less 
effective. This implies that the neutron RBE at a 
neutron dose of 16 mGy must exceed 17.5. To indicate 
this, the excluded ränge RBE less than 17.5 is blocked 
out by a solid vertical line in text-figure 11. The other 
vertical lines are obtained in the same way from other 
comparisons. Because there are only 3 X-ray doses in 
the present experiment, earlier gamma ray data (7) 
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T E X T - F I G U R E 10.—Forward shift in time of occurrence of FA due to 
neutron or X-ray exposure. Scales for the neutron dose (D„) and 
the X-ray dose (Dx) differ by a factor of 10. Time shifts are ob-
tained from the data in text-fig. 4. 
have also been utilized for the comparisons. The vertical 
bars indicate that the effects are different on a signifi-
cance level of more than 95%. The arrows indicate 
differences with less Statistical significance. The band 
of RBE values between the set of vertical bars is 
consistent with the curve that corresponds to the dose-
effect relations in text-figures 1, 2, 9, and 10. 
Only a minor fraction (14%) of all mammary neo-
plasms found in this study were mammary AC. No 
separate dose-effect relations are given for AC, but 
there is no evidence that their dose dependence differs 
from that of the FA. In particular, the RBE-dose 
dependence plotted in text-figure 11 for FA and the 
combined group of FA and AC is consistent also for 
the more limited data pertaining to AC. Due to 
Statistical uncertainties at low doses, differences in the 
occurrence of FA and A C cannot be excluded. How-
ever, Statistical tests show a significantly faster rise in 
the A C rate for 0.064 Gy of neutrons than for 0.85 Gy 
of X-rays. The neutron RBE for AC at 0.064 Gy can 
therefore be taken to be approximately 13, and this 
value is in agreement with the value for FA. 
1000 
.001 .01 .1 
NEUTRON DOSE /GRAY 
T E X T - F I G U R E 11.—Dependence of the R B E of neutrons for the induc-
tion of mammary neoplasms on neutron dose. Vertical bars indi-
cate the ranges of R B E that are excluded on a level of Statistical 
significance exceeding 95%; arrows represent differences with lower 
level of significance. This analysis utilizes a nonparametric method 
(23) and is based on the current results and on earlier data (7) for 
gamma rays. The graph applies equally whether one considers FA 
only or both types of neoplasms. 
CONCLUSIONS 
The present experiment has been designed toward 
the assessment of the effect of very low doses of 
neutrons in comparison to that of sparsely ionizing 
radiations. 
Even a single dose of 1 mGy of neutrons (0.1 rad) 
produces a significant increase in the tumor rate in 
regard to mammary FA and in regard to the total 
mammary neoplastic response which includes both FA 
and AC. A comparison of various exposed groups leads 
to RBE values of neutrons that increase beyond the 
value 100 at low doses. At high doses one obtains 
substantially smaller RBE values. This RBE-dose rela-
tionship is consistent with the theoretically expected 
(/) proportionality of RBE to the inverse Square root of 
the neutron dose and with the high values of RBE at 
small neutron doses. 
Dose-effect relationships can be obtained in various 
forms. Regardless of whether one considers the number 
of excess tumors at a specified time, the forward shift 
in tumor rates, or the loss of tumor-free life-span, the 
resulting dose-effect relationships for neutrons gener-
ally correspond to a dose exponent of approximately 
0.5. The data for X-rays appear to be consistent with a 
dose exponent of 1; however, the apparent linearity of 
the dose-effect relationships for X-rays may be fortui-
tous. 
The number of radiation-induced AC is too small to 
permit definite Statements on the dose-effect relation-
ships. However, the high RBE values for neutrons and 
the RBE-dose relationship that applies to FA appear to 
pertain also to AC. 
APPENDIX 
Estimates of Integral Tumor Rate R ( t ) and 
Cumulative Prevalence l ( t ) 
In agreement with the formula derived by Kaplan 
and Meier {14), one can use the so-called "product 
limit estimate" of the cumulative prevalence: 
/ ( < ) = 1 - p ( 1 - ^ ö ) ^ ' ' [ A 1 ] 
where the product extends over all times tk of occur-
rence of a first tumor. N(tk) is the number of animals 
without neoplasms before tk-
In the present article, the relation between I(t) and 
the integral tumor rate R(t) (from first tumors) 
l ( t ) = \ - e [A.2] 
is used, and R(t) is estimated by the formula that, in 
analogy to equation A . l , can be termed the "sum limit 
estimate": 
[A.3] 
Equation A<3 is more convenient numerically. It also 
has the advantage that it can be applied to all tumors 
instead of first tumors only. 
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The numerical values obtained with the two differ-
ent estimates are very nearly equal provided the num-
ber of animals is not too small. If N ( t k ) is large 
compared to 1, one has the approximate equality 
[A.4] 
' n 0 N ( t k ) ) N ( t k y 
Accordingly, one obtains 
/ ( 0 = , - n ( i — u = w ? ' n 
k\ N { t k ) / 
-R(t) = \-e 
Standard Errors of R ( t ) and l ( t ) 
[A.5] 
The Standard deviation of the estimate of R(t) can be 
deduced from equation 4. If the neoplasms are statisti-
cally independent, the variance of the observed quantity 
R ( t ) is the sum of the variances of the individual terms 
r i i / N i . Since m follows a Poisson distribution, the esti-
mated variance of n, is also equal to n,. The estimated 
variance of m / N i is therefore m / N i 2 . Accordingly, one 
obtains an estimate of the variance of R ( t ) as the sum 
of variances of all terms in equation 4: 
2 ^ TU 
° R(t)=2r*T72, summation over all i with i & t < t . [B.l] 
By considering sufficiently short time intervals, one 
obtains a relationship analogous to equation 5: 
o j?(o = Lx,/ a » summation over all k with t k < t , 
k N ( t k ) [ß 2] 
where tk are the times of appearance of the individual 
tumors, and N ( t k ) are the numbers of survivors at these 
times. The corresponding Standard error OR{D (see 
equation 6) has been represented in text-figures 4 and 5 
by the shaded areas. 
The assumption of the independence of mammary 
neoplasms is not strictly valid. An analysis of the 
frequencies of multiple tumors among the animals 
surviving at specified times indicates deviations from 
the Poisson distribution that are due to differences in 
tumor rate among the animals. The effect is significant 
toward the later part of the Observation period; the 
indicated Standard errors are then somewhat too small. 
The Standard error o/u) of the cumulative prevalence 
is usually obtained from the Greenwood formula ( 1 4 ) : 
a/(o = (l-/(0)-ZT777r^—-> t k < t . [B.3] 
k N ( t k ) ' N ( t k - i ) 
One obtains nearly the same values whether one plots 
l(t)±oi(t) or, as in text-figure 8, \ - e x p ( - R ( t ) ± O R ( T ) ) . The 
consistency of the two Standard errors follows from the 
fact that they are in the proper relationship: 
°nt) -
dl(t) 
dR(t) 
[B.4] 
d l ( t ) _ 
dR(t) dR(t) 
[B.5] 
and 
1 
k N ( t k ) N ( t k - i ) 
d l { t ) * 1 
d R ( t ) k N ( t k ) 
d l { t ) 
'dR(t) '°R(t)-
[B.6] 
that results from 
The estimate for ORU) used in the present article is 
therefore consistent with the Greenwood formula. 
In a detailed study of radiation carcinogenesis, the 
main objective is the analysis of the tumor rate and the 
integral tumor rate. Accordingly, the sum limit esti-
mate and the corresponding formula for the Standard 
error are used instead of the product limit estimate and 
the Greenwood formula. 
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